Purpose. A recently identified colistin resistance gene, mcr-1, has been reported in many countries. In this study, we established a new real-time PCR method to detect it.
INTRODUCTION
Antimicrobial resistance is considered one of the most urgent public health problems of the twenty-first century. The phenomenon of antibiotic resistance threatens to affect human health worldwide. This problem has intensified following the emergence of carbapenem-resistant strains of Enterobacteriaceae, leaving colistin as one of the few remaining clinical treatment options for the treatment of infections which caused by carbapenemresistant strains of Enterobacteriaceae. However, colistin is also widely used to treat infected animals, especially in China [1, 2] .
In 2016, Liu and colleagues reported a plasmid-mediated colistin-resistance (designated mcr-1) gene in China. The mcr-1 gene encodes a lipid A phosphoethanolamine transferase that is capable of inactivating colistin [1] . It has subsequently been found that the mcr-1 gene is not only carried by different plasmids, but also located on the chromosome [1, [3] [4] [5] [6] [7] [8] . Several MCR-1-positive Enterobacteriaceae have been isolated from both humans and animals in many different countries. These observations suggest that the mcr-1 gene has been disseminated globally and is likely to impact both clinical and animal husbandry treatment strategies [9] [10] [11] [12] [13] . Thus, active surveillance pertaining to mcr-1 gene dissemination is of paramount importance.
In this study, a novel real-time PCR assay was developed and used to detect the mcr-1 gene in a variety of isolates from human and pet faecal samples in China.
METHODS
Isolates and faecal samples A total of 2330 Gram-negative isolates were investigated in this study. These isolates from 20 provinces and municipal cities in China were obtained between 1998 and 2015. The species pertaining to these Gram-negative isolates are listed in Table 1 , and the geographical distribution details are presented in Fig. 1 . Detailed information relating to isolate screening is shown in Table 2 . The number of isolates obtained during the years 2010 to 2015 (n=2014) was much more than the number of isolates obtained before 2010 (n=316). The pathogenic Escherichia coli isolates were identified by virulence gene PCR-typing and serotyping as done in a previous study [14] . Most of the isolates were collected from human faeces (from diarrhoea patients and healthy humans), poultry faeces (from broilers) and livestock faeces (from swine, cattle, goats and mutton sheep). A small proportion of the isolates were from commercially available food (from vegetables, chicken, pork, beef, meat stuffing, cured meat and animal innards), insects (from dung beetles and flies), fowl faeces (from egrets and pigeons), rodent intestinal contents (from pikas and marmots) and environmental samples (from fences and water in swine farms). The top three areas in respect of the number of isolates that were collected were Shandong, Henan and Beijing.
A total of 337 faecal samples were collected from Beijing and Hainan provinces between 2014 and 2015. Among these, 229 (159 and 70 samples from Beijing and Hainan, respectively) were obtained from humans and 108 (from a single Beijing animal hospital) were obtained from pet animals (77 from dogs and 31 from cats).
DNA extraction
DNA from bacterial isolates and standard strains was extracted using a commercial DNA extraction kit (TIAN-GEN TIANamp Bacteria DNA kit; TIANGEN BIOTECH). DNA from faecal samples was extracted using a commercial QIAamp stool extraction kit (QIAGEN). All of the extracted DNA templates were stored at À20 C until further required.
Real-time PCR primers, fluorescence probe for mcr-1 gene and real-time PCR assay Real-time PCR primers and minor groove binder (MGB)-conjugated fluorescent probes were designed to amplify a 102 base pair DNA fragment (positions 143 to 244) from the mcr-1 coding region (GenBank no. KP347127). The forward primer (5¢-TCG GCT TTG TGC TGA CGA T-3¢), the reverse primer (5¢-AAA TCA ACA CAG GCT TTA GCA CAT A-3¢) and the 6-carboxyfluorescein (FAM)-labelled mcr-1-specific probe (5¢-FAM-CTG TCG TGC TCT TTG-MGB-3¢) used in this study were procured from Shanghai GeneCore Biotechnologies. The LightCycler 480 II (Roche Diagnostics) was used for the amplification and detection of the mcr-1 gene. Each PCR run included a negative control, an external mcr-1-positive control and an internal processing control (16S rDNA locus). The amplification conditions were 95 C for 180 s followed by 40 quantitative cycles of 95 C for 5 s, 58 C for 20 s and 40 C for 20 s.
Construction of the recombinant plasmid carrying the mcr-1 gene The pEASY-T5 Zero Cloning kit (TRANSGEN BIOTECH) was used to generate a plasmid harbouring the mcr-1 genespecific fragment (using the primers described above and a whole mcr-1 gene-carrying plasmid) to measure copy number. The number of mcr-1 gene plasmid copies was calculated using the value for the plasmid molecular weight and the following formula:
Standard plasmid copies µl The PCR LightCycler 480 Probes Master kit (Roche Diagnostics) was used to generate standard plasmid serial dilutions, and nine concentration gradients from 1.0Â10 0 to 1.0Â10 8 copies µl À1 of standard plasmids were generated. Concentration gradient generation was performed in triplicate for standard curve construction and sensitivity evaluation.
Simulated faecal samples and mcr-1 detection evaluation An E. coli strain containing a whole mcr-1 gene-carrying plasmid was used as a control and cultured overnight in brain-heart infusion broth until the culture reached an OD 600 of 0.6. A plate-counting assay confirmed that the culture contained 2.2Â10 8 c.f.u. ml
À1
. Nine concentration gradients from 1.1Â10 0 to 1.1Â10 8 c.f.u. ml À1 were generated by serial dilution. These dilutions were added to healthy human faeces to generate simulated mcr-1-positive faecal samples. DNA from faecal samples was extracted as described above.
Determination of specificity of the mcr-1 PCR method Escherichia coli strain ATCC 25922, Acinetobacter lwoffi strain ATCC 15309 and Pseudomonas aeruginosa strain ATCC 27853 do not harbour the mcr-1 gene and were used as negative control strains. Genomic DNA extracted from these strains was used to evaluate the specificity of the mcr-1 gene PCR method.
RESULTS
Sensitivity and specificity of the mcr-1 gene PCR assay A recombinant plasmid containing the mcr-1 gene was serially diluted to generate nine concentration gradients (from 1.0Â10 0 to 1.0Â10 8 copies µl À1 ) to determine the Provinces/municipal cities where mcr-1 screening was carried out and mcr-1-positive isolates were detected in this study. The areas in colour: provinces/municipal cities where isolates and/or faecal samples were collected. Pink: only isolates; yellow: isolates and faecal samples. Spots in colour represent areas where mcr-1-positive samples were isolated or detected. Blue spots: non-pathogenic E. coli strains; red spots: EPEC strains; yellow spots: EAEC strains; green spots: faecal samples. Grey bar represents mcr-1 screening area previously described by Liu et al.
limit of detection by copy number. The detection limit of this mcr-1 gene PCR method was determined to be 1.0Â10 1 copies per reaction, and a C t value of less than 35 was considered as mcr-1-positive for the sample tested.
We next determined the detection limit for the assay by colony counting using the simulated faecal sample. This sample was diluted to between 1.1Â10 3 and 1.1Â10 8 c.f.u. ml À1 mcr-1 positive E. coli. The limit of mcr-1 detection by PCR was 1.1Â10 3 c.f.u. ml
À1
, and a C t value of less than 35 was considered as mcr-1-positive. We did not perform dilutions lower than 1.1Â10 3 c.f.u. ml
; thus, the detection limit may be even lower.
To evaluate the specificity of the assay, an mcr-1 recombinant plasmid was used as positive control. The three negative control strains, E. coli ATCC 25922, A. lwofii ATCC 15309 and P. aeruginosa ATCC 27853, did not produce a positive signal.
Screening of mcr-1 in a large collection of isolates from different species A total of 2330 isolates were screened using the newly established PCR method. The isolates were obtained from 20 different geographical regions and consisted of both human and farm animal isolates (see Table 2 ). Fifty-four of the tested isolates (2.3 %) were positive for the mcr-1 gene (see Table 3 ). Interestingly, all of the 54 mcr-1-positive strains were E. coli (54/1709, 3.2 %) including one (1/128, 0.8 %) enteroaggregative E. coli (EAEC) isolate, nine (9/402, 2.2 %) enteropathogenic E. coli (EPEC) isolates and 44 (44/697, 6.3 %) nonpathogenic E. coli isolates. The pathogenic E. coli isolates were obtained from a variety of sources (diarrhoea patients, healthy human, commercially food, livestock or poultry), and the nonpathogenic E. coli isolates were from farm environment, livestock and poultry faeces (For details, see Table 3 ). The mcr-1-positive isolates were obtained from human faeces (3/1161, 0.3 %), livestock and poultry faeces (45/ 981, 4.6 %), food (4/103, 3.9 %) and environmental samples (2/9, 22.2 %) between 2010 and 2014. The oldest isolate was obtained from a faecal livestock sample in Xinjiang province in 2010, and the majority of mcr-1-positive isolates were from farm animals in Xinjiang (30 isolates, four from goat faeces in 2010, one from swine faeces in 2010, one from cattle faeces in 2012 and 24 from swine faeces in 2013) and Shandong province (12 isolates, all from poultry faeces). Screening of mcr-1 gene in human and pet animal faecal samples A total of 337 faecal samples (229 from hospital inpatients and 108 from pet animals) were screened for mcr-1. Fourteen samples (4.2 %) were mcr-1-positive (Table 4 ). The positive rate was lower in inpatient samples than pet samples with six (2.6 %) positive inpatient faecal samples and eight (7.4 %) positive pet animal faecal samples identified, respectively. None of the 159 human faecal samples from Beijing was mcr-1-positive while six of the 70 (8.6 %) human faecal samples from Hainan were mcr-1-positive.
DISCUSSION
Sensitivity and specificity of the mcr-1 PCR assay The mcr-1 gene was a new polymyxin resistance gene that was described last year [1] . In this study, a new PCR method was developed to detect mcr-1. The detection limit of the mcr-1 gene, which was determined using a plasmid standard curve analysis and simulated faecal sample detection, was 1.0Â10 1 copies per reaction system and 1.1Â10 3 c.f.u. ml
À1
, respectively. None of the mcr-1 negative strains resulted in the generation of an amplification curve. Thus, the new mcr-1 gene PCR method developed in this study displayed high sensitivity and specificity. This method is simple and rapid, and can be used for mcr-1 detection in clinical, animal husbandry and food samples. From screening a large collection of isolates, human and pet animal faecal samples, we demonstrated that this PCR method is effective for direct detection of the mcr-1 gene from faecal specimens.
Dissemination of the mcr-1 gene throughout China Liu and colleagues have reported that a plasmid-mediated colistin resistance gene, mcr-1, can be carried by E. coli and Klebsiella pneumoniae isolates from animals and inpatients in the south of China [1] . Our study expanded the geographic coverage by investigating whether mcr-1 was present in isolates from 19 new provinces and municipal cities. This study also analysed a variety of sources including faeces from livestock, poultry, fowl, rodents and humans, along with food and environmental samples (see Fig. 1, Table 2 ). A total of 54 out of 2330 isolates and 14 out of 337 faecal samples were identified to be mcr-1-positive. We also observed that mcr-1 isolates were present in eight 'new' regions of China including Xinjiang in the far northwest and Heilongjiang in the far northeast, suggesting that mcr-1 is widespread in China (Fig. 1) . For the mcr-1-positive isolates detected in this study, we found that the mcr-1-carrying plasmids were different sizes varying from less than 60 to 150 kb (data not shown), suggesting transfer of the mcr-1 gene between plasmids. Liu et al. [1] showed that the flanking sequences of the mcr-1 gene were homologous in some of their isolates, also suggesting transfer of the mcr-1 gene between plasmids. Other studies have shown that the mcr-1 gene could be transmitted through conjugative plasmids [1, [3] [4] [5] [6] 15] . Further studies will be needed to elucidate the mechanisms of the mcr-1 gene.
Up until now, the mcr-1 gene has predominantly been found in Enterobacteriaceae isolates [1, 2, [16] [17] [18] [19] [20] [21] , especially in E. coli strains. Moreover, all of the mcr-1-positive isolates from this study were E. coli strains. Importantly, 10 of the strains isolated between 2011 and 2014 were pathogenic E. coli. Three of these pathogenic E. coli isolates (one EAEC strain and two EPEC strains) were obtained from humans, although colistin is not currently used in the routine treatment of E. coli infections. The presence of mcr-1-positive pathogenic E. coli isolates in infected patients highlights the potential threat to human health, with polymyxins previously representing 'the last line' of therapeutic agents to combat multidrug resistant Gram-negative infections. Previous studies have shown that the prevalence of the mcr-1 gene is lower in E. coli strains of human origin compared with strains isolated from animal and food samples [1, 10, 15, 18] . Our data are consistent with these findings. The mcr-1-positive rate in human isolates is 0.3 % (3/1144) while the rate in commercial food isolates and in livestock and poultry faecal isolates were 5.6 % (4/72) and 6.3 % (45/718), respectively. Overall our rate is lower than those reported by Liu and colleagues, in which the mcr-1-positive rate was 1.2 % in humans, 14.9 % in raw meat samples (pork and chicken), and 20.7 % in swine [1] . However, the difference in positive rates may be due to regional difference, sample type difference and difference in the years when the isolates were collected.
In our study, the mcr-1-positive isolates were collected between 2010 and 2014. Most of our mcr-1-positive strains were isolated in 2013 and the oldest isolate was collected from a Xinjiang province livestock faecal sample in 2010. However, the first observation of the mcr-1 isolate in China occurred in the 1980s and rapid increase of mcr-1 prevalence in E. coli from poultry was observed from 2011 onwards [2] . In the first report of mcr-1 by Liu et al. [1] , the positive rate was also higher in 2012-2014 isolates, than in 2011 isolates including isolates from pigs at slaughter house and chicken and pork meat. All data suggest that mcr-1 prevalence has been rapidly increasing in recent years.
Direct detection and prevalence of the mcr-1 gene in human and pet animal faecal samples in Beijing and Hainan In this study, we detected the mcr-1 gene in faecal samples using a PCR method and observed that six human and eight pet faecal samples were mcr-1-positive.
It has been suggested that pets can transmit mcr-1 E. coli [22] . To the best of our knowledge, our study is the first report to show that the mcr-1 gene has been directly detected in pet faecal samples. Since pets are in direct and frequent contact with humans, it needs to be recognized that pets act as a reservoir for colistin-resistant bacteria and are potentially an important source of human infective colistin-resistant bacteria. All of the mcr-1-positive human faecal samples were from Hainan while none of the human faecal samples from Beijing was mcr-1-positive, suggesting that there is a regional difference in its prevalence in the human population. However, it could also be due to sampling. Considering that the two EPEC isolates from food samples and eight pet faecal samples were mcr-1-positive from Beijing, it is likely that mcr-1-positive E. coli is present in the human population in Beijing though it has not been sampled in this study.
In conclusion, we utilized a newly established PCR method to screen a large collection of bacterial isolates from more than 10 species. We examined 2330 isolates of different species and found that only E. coli isolates carried the mcr-1 gene. The mcr-1-positive rate was 2.3 % for all isolates and 3.2 % for E. coli. Screening of pet animal faecal samples from Beijing suggested an mcr-1-positive rate of 7.4 %. Thus, mcr-1-mediated resistance is not exclusive to humans and farm animals but also occurs in pet animals. Our study also extends the number of provinces and municipal cities, including Xinjiang, Hainan and Heilongjiang, in China where mcr-1 dissemination has been reported. Our study highlights the importance of active surveillance in relation to the nationwide and global spread of mcr-1. Finally, to facilitate a more holistic surveillance strategy, the PCR detection method that was developed as part of this study should be employed to test for the presence of mcr-1 in both isolates and faecal samples.
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